Yep. Pretty grim situation now. Just a matter of planning an exit and dumping this pos. I predicted we wouldn’t hear from them by the end of September. You would think that would have been big news for a little company. Not Failing Biosciences. They’re just interested in how much they make off of their financing scheme.
News 
Market Data 
Discover 
AI
